Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus

Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus

Objective: American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA) guidelines suggest that linezolid (LZD) is preferred over vancomycin (VCM) for treating methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. We conducted a systematic review and comparative meta-analysis...

Full description

Bibliographic Details
Main Authors: Hideo Kato, Mao Hagihara, Nobuhiro Asai, Yuichi Shibata, Yusuke Koizumi, Yuka Yamagishi, Hiroshige Mikamo
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Meta-analysis
Vancomycin
Linezolid
Methicillin-resistant Staphylococcus aureus
Pneumonia
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716520303234

Internet

http://www.sciencedirect.com/science/article/pii/S2213716520303234

Similar Items